Eisai Targeting Global Leadership in Neurology & Oncology…
Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma player, with pharmaceutical revenues of…
Tagged with Neurology
Chantal Depondt – President, Belgian Neurological Society…
Chantal Depondt, president of the Belgian Neurological Society (BNS), introduces the mission of the professional association and offers her insights…
Catherine Rives – General Manager, UCB France
Newly-appointed general manager of UCB France, Catherine Rives, discusses what drew her back to the company after time away, market access issues in…
Interview: Terry O'Regan – Vice President and Managing…
Terry O’Regan, VP and managing director at Biogen UK and Ireland, discusses the company’s longstanding commitment to the UK, market access issues,…
John Hardy – Professor of Neuroscience, Institute of…
Recipient of the 2018 Brain Prize for research for groundbreaking research on the generic and molecular basis of Alzheimer’s Disease, the UCL’s…
Interview: Alessandro di Napoli – CEO, TRB Chemedica,…
Alessandro di Napoli, CEO of Swiss family-owned pharmaceutical group, TRB Chemedica, discusses the company’s focus on the rheumatology,…
FDA New Drug Approvals 2017
In 2016, rumours of a weakening FDA followed a disappointing 16 new drugs approved for the full year. However, since the beginning of 2017 the FDA has…
Konstantinos Kofinas – Managing Director Greece &…
Appointed in the midst of the Greek economic crisis, compounded by significant changes at the corporate Merck brand, Merck Greece’s MD, Konstantinos…
Interview: Alberto Guglielmo – President, Carlo Besta…
Alberto Gugliemo, President of the Carlo Besta Institute in Milan, shares the changing perception of neurological diseases and neurological science in…
Interview: Pascal Brossard – Managing Director, Zambon…
Pascal Brossard, the Managing Director of Zambon France and President of Afipa (Association for the French self-medication medicines industry),…
Interview: Thomas Würdinger – Head of Neuro-Oncology at…
Thomas Würdinger, winner of the 2014 Galenus prize, discusses his research team’s efforts to developing new treatment options and protocols for…
Interview: Diane Gosselin, President and CEO, CQDM, Canada
The president & CEO of CQDM discusses her vision of how CQDM’s activities can have a direct impact on the development of safer and more…
